Results 1 - 10 of 91 (Click here to explore results)

<

1

2

3

...

9

10

>

Exploring a structural protein–drug interactome for new therapeutics in lung cancer. Xiaodong Peng, Fang Wang, Liwei Li, Khuchtumur Bum-Erdene, David Xu, Bo Wang, Anthony A. Sinn, Karen E. Pollok, George E. Sandusky, Lang Li, John J. Turchi, Shadia I. Jalal, Samy O. Meroueh , Mol. BioSyst. , 2014 , 10 , 581

Approaches to pseudopeptidic ergopeptines. Part 3.1 Consequences of the incorporation of an α-azaphenylalanine residue into the ergotamine oxa-cyclolic system . Anna Calcagni, Gino Lucente, Grazia Luisi, Francesco Pinnen, Domenico Rossi, Enrico Gavuzzo , J. Chem. Soc., Perkin Trans. 1 , 1997 , 2223

Resolution and quantification challenge of modern chemometric models in the determination of anti-migraine tablets containing ergotamine, caffeine, acetaminophen, and metoclopramide. Mahmoud M. Elkhoudary, Randa A. Abdel Salam, Ghada M. Hadad , RSC Adv. , 2017 , 7 , 20936

Recent progress in ergot alkaloid research. Jing-Jing Chen, Meng-Yao Han, Ting Gong, Jin-Ling Yang, Ping Zhu , RSC Adv. , 2017 , 7 , 27384

Ergot alkaloids: structure diversity, biosynthetic gene clusters and functional proof of biosynthetic genes. Christiane Wallwey, Shu-Ming Li , Nat. Prod. Rep. , 2011 , 28 , 496

Expanding the horizons of G protein-coupled receptor structure-based ligand discovery and optimization using homology models. Claudio N. Cavasotto, Damián Palomba , Chem. Commun. , 2015 , 51 , 13576

Biosynthesis of the ergot alkaloids. Dorota Jakubczyk, Johnathan Z. Cheng, Sarah E. O'Connor , Nat. Prod. Rep. , 2014 , 31 , 1328

Outlining migrainous through dihydroergotamine–serotonin receptor interactions using quantum biochemistry. José X. Lima Neto, Vanessa P. Soares-Rachetti, Eudenilson L. Albuquerque, Vinicius Manzoni, Umberto L. Fulco , New J. Chem. , 2018 , 42 , 2401

The alkaloids of ergot. George Barger , Analyst , 1937 , 62 , 340

CLXXX.—The alkaloids of ergot. Part I. Sydney Smith, Geoffrey Millward Timmis , J. Chem. Soc. , 1930 , 1390